Study to check the safety and performance of stent in all comer patients with de novo coronary artery disease .
- Conditions
- Chronic ischemic heart disease, unspecified,
- Registration Number
- CTRI/2022/12/048054
- Lead Sponsor
- Sahajanand Laser Technology Ltd
- Brief Summary
A retrospective, single-arm, multi-center, observational, post-market clinical follow-up study to evaluate the safety and performance of FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent System in patients with de novo coronary artery disease under real-world settings. The clinical endpoints are target lesion failure, cardiovascular death, target vessel myocardial infarction, clinically-driven target lesion revascularisation (CD-TLR), stent thrombosis (ST), target vessel failure (TVF), target vessel revascularization at 12 months, 3 years, 5 years follow-up. Total Number of 500 patients will be enrolled who have been implanted with FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent .
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 500
All patients implanted with FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent System.
Patients who are not implanted with FlexyRap Cobalt Chromium Rapamycin Eluting Coronary Stent System.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Target Lesion Failure which is defined as a composite of cardiovascular death, target vessel myocardial 12 Months infarction (TV-MI) and clinically driven target lesion revascularization 12 Months
- Secondary Outcome Measures
Name Time Method Cardiovascular Death Target Vessel Myocardial Infarction
Trial Locations
- Locations (5)
Cardinova Institute of Medical Science
🇮🇳Jalandhar, PUNJAB, India
CAREMAX Hospital
🇮🇳Jalandhar, PUNJAB, India
EMC Super Speciality Hospital
🇮🇳Amritsar, PUNJAB, India
Moga Medicity Hospital
🇮🇳Moga, PUNJAB, India
Sunshine Global Hospital
🇮🇳Surat, GUJARAT, India
Cardinova Institute of Medical Science🇮🇳Jalandhar, PUNJAB, IndiaDr Nitish GargPrincipal investigator9736088888nitishgarg@yahoo.com